Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Albert David
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 81 | 92 | 93 | 88 | 89 | 89 | 98 | 83 | 75 | 71 | 87 | 90 | 86 |
| Expenses + | 72 | 79 | 77 | 80 | 79 | 88 | 92 | 82 | 80 | 81 | 85 | 79 | 83 |
| Operating Profit | 10 | 13 | 16 | 8 | 10 | 1 | 6 | 1 | -5 | -11 | 3 | 11 | 3 |
| OPM % | 12% | 14% | 17% | 9% | 11% | 1% | 6% | 1% | -6% | -15% | 3% | 12% | 3% |
| Other Income + | 0 | 18 | 12 | 17 | 10 | 23 | 21 | -9 | -5 | 22 | -2 | 12 | -25 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 7 | 29 | 27 | 23 | 18 | 22 | 25 | -10 | -12 | 8 | -3 | 20 | -25 |
| Tax % | 48% | 20% | 24% | 20% | 29% | 15% | 28% | -8% | -13% | 6% | 28% | 23% | -15% |
| Net Profit + | 4 | 23 | 20 | 19 | 13 | 19 | 18 | -9 | -10 | 8 | -3 | 15 | -21 |
| EPS in Rs | 6.54 | 41.16 | 35.57 | 32.80 | 22.62 | 33.01 | 31.66 | -16.45 | -18.10 | 13.91 | -5.78 | 26.81 | -37.55 |
Financials of Albert David
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 317 | 318 | 293 | 285 | 316 | 320 | 246 | 313 | 341 | 362 | 345 | 334 |
| Expenses + | 281 | 286 | 266 | 267 | 286 | 289 | 227 | 272 | 297 | 315 | 342 | 328 |
| Operating Profit | 37 | 31 | 27 | 18 | 30 | 30 | 19 | 41 | 44 | 47 | 3 | 5 |
| OPM % | 12% | 10% | 9% | 6% | 10% | 10% | 8% | 13% | 13% | 13% | 1% | 2% |
| Other Income + | 2 | 43 | 8 | 9 | 15 | 7 | 17 | 16 | 15 | 58 | 30 | 7 |
| Interest | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 3 |
| Depreciation | 15 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 9 | 7 | 7 | 10 |
| Profit before tax | 20 | 63 | 26 | 18 | 38 | 29 | 27 | 47 | 51 | 97 | 25 | 1 |
| Tax % | 32% | 24% | 39% | 45% | 29% | 34% | 19% | 25% | 29% | 22% | 32% | 379% |
| Net Profit + | 14 | 48 | 16 | 10 | 27 | 19 | 22 | 35 | 36 | 75 | 17 | -1 |
| EPS in Rs | 24.00 | 84.10 | 27.96 | 17.24 | 46.68 | 33.59 | 38.79 | 61.78 | 63.38 | 132.15 | 30.14 | -2.61 |
| Dividend Payout % | 23% | 7% | 20% | 32% | 13% | 21% | 15% | 15% | 14% | 9% | 17% | -192% |
Financials of Albert David
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 87 | 131 | 177 | 180 | 205 | 217 | 239 | 274 | 306 | 377 | 387 | 386 |
| Borrowings + | 30 | 20 | 30 | 28 | 0 | 2 | 2 | 6 | 5 | 3 | 12 | 30 |
| Other Liabilities + | 71 | 67 | 71 | 76 | 84 | 95 | 95 | 116 | 106 | 112 | 107 | 98 |
| Total Liabilities | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 | 519 |
| Fixed Assets + | 49 | 44 | 87 | 83 | 77 | 91 | 84 | 88 | 80 | 83 | 99 | 100 |
| CWIP | 5 | 5 | 9 | 5 | 5 | 2 | 1 | 1 | 3 | 7 | 2 | 21 |
| Investments | 16 | 48 | 59 | 68 | 113 | 122 | 138 | 183 | 193 | 273 | 260 | 243 |
| Other Assets + | 122 | 127 | 130 | 134 | 99 | 106 | 119 | 130 | 148 | 135 | 151 | 155 |
| Total Assets | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 | 519 |
Financials of Albert David
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 28 | 68 | 20 | 30 | 32 | 30 | 37 | 40 | 11 | 46 | -28 | -8 |
| Cash from Investing Activity + | -9 | -38 | -36 | -11 | -19 | -20 | -37 | -40 | -5 | -33 | 23 | -4 |
| Cash from Financing Activity + | -18 | -18 | 7 | -5 | -17 | -10 | -2 | -2 | -6 | -8 | 0 | 12 |
| Net Cash Flow | 1 | 12 | -10 | 15 | -4 | 0 | -2 | -1 | -1 | 4 | -5 | -0 |
| Free Cash Flow | 18 | 62 | -0 | 31 | 45 | 15 | 35 | 32 | 6 | 35 | -43 | -36 |
| CFO/OP | 95% | 303% | 115% | 204% | 126% | 149% | 202% | 129% | 59% | 131% | -629% | -49% |
Financials of Albert David
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 41 | 41 | 35 | 25 | 34 | 29 | 29 | 32 | 30 | 29 | 37 |
| Inventory Days | 176 | 187 | 217 | 173 | 151 | 148 | 151 | 124 | 149 | 126 | 201 | 187 |
| Days Payable | 103 | 102 | 117 | 127 | 102 | 132 | 104 | 96 | 95 | 98 | 118 | 104 |
| Cash Conversion Cycle | 120 | 126 | 141 | 81 | 74 | 50 | 76 | 57 | 87 | 58 | 112 | 120 |
| Working Capital Days | 27 | 25 | 24 | 10 | 21 | 18 | -10 | -34 | 14 | -13 | 6 | 247 |
| ROCE % | 18% | 17% | 15% | 7% | 18% | 14% | 12% | 17% | 17% | 28% | 6% | 1% |
Focused growth in six core therapy areas: cardiology, pain management, women's health, CNS, transplant, and ophthalmology, which contribute 40-50% of…
Expansion plans supported by capex of INR 200-250 crores annually, with 60% towards expansion/new products and 40% towards efficiency improvements. Key concall…
The company is confident of achieving 20%+ volume growth backed by steady ramp-up in Jammu and existing facilities. Key concall takeaways from Innova Captab…
Chronic respiratory segment in India showing over 25% growth; oncology and cardiovascular segments also strong. Key concall takeaways from Glenmark…